CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Stemline Therapeutics Inc  (STML)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 
 

STML's Income from Cont. Operations Year on Year Growth by Quarter and Year

Stemline Therapeutics Inc's Income from Cont. Operations results by quarter and year



Select the Comparisons : Select the Ratio:                        

STML Income from Cont. Operations (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - -10.01 -10.18 -6.93
III Quarter September -16.06 -9.92 -9.23 -6.89
II Quarter June -15.46 -9.32 -10.15 -6.01
I Quarter March -14.57 -9.05 -7.68 -9.00
FY   -46.09 -38.30 -37.24 -28.83

Financial Statements
Stemline Therapeutics Inc's third quarter 2017 Income from Cont. Operations $ -16.06 millions STML's Income Statement
Stemline Therapeutics Inc's third quarter 2016 Income from Cont. Operations $ -9.92 millions Quarterly STML's Income Statement
STML's Growth by Division See STML's Growth by Segment

STML Income from Cont. Operations ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -





STML Income from Cont. Operations Growth Comment
Stemline Therapeutics Inc in the third quarter recorded loss from Cont. Operations of $ -16.06 millions.

According to the results reported in the third quarter, Stemline Therapeutics Inc achieved the best Income from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Stemline Therapeutics Inc' s Income from Cont. Operations no change of % ranks overall at the positon no. 0 in the third quarter.



Income from Cont. Operations Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

You need to upgrade your Flash Player

Other Income from Cont. Operations Growth
Major Pharmaceutical Preparations Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
STML's Income from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for STML's Competitors
Income from Cont. Operations Growth for Stemline Therapeutics Inc's Suppliers
Income from Cont. Operations Growth for STML's Customers

You may also want to know
STML's Annual Growth Rates STML's Profitability Ratios STML's Asset Turnover Ratio STML's Dividend Growth
STML's Roe STML's Valuation Ratios STML's Financial Strength Ratios STML's Dividend Payout Ratio
STML's Roa STML's Inventory Turnover Ratio STML's Growth Rates STML's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Sep 30 2017 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Sep 30 2017
Addus Homecare Corp  100.59 %$ 100.589 millions
Baxter International Inc  95.28 %$ 95.276 millions
Medpace Holdings, Inc.  95.21 %$ 95.214 millions
Radnet, Inc.  93.32 %$ 93.320 millions
Ani Pharmaceuticals Inc  85.61 %$ 85.608 millions
Halyard Health, Inc.  82.42 %$ 82.418 millions
Petmed Express Inc  78.81 %$ 78.812 millions
Integrity Applications, Inc.  77.68 %$ 77.677 millions
United Therapeutics Corp  70.77 %$ 70.766 millions
Emergent Biosolutions Inc.  64.56 %$ 64.562 millions
Align Technology Inc  60.72 %$ 60.716 millions
Steris Plc  60.30 %$ 60.300 millions
Innoviva, Inc.  58.10 %$ 58.099 millions
Lemaitre Vascular Inc  56.15 %$ 56.147 millions
Pra Health Sciences, Inc.  54.55 %$ 54.555 millions
Pdl Biopharma, Inc.  49.11 %$ 49.108 millions
Regeneron Pharmaceuticals Inc  46.64 %$ 46.643 millions
Intuitive Surgical Inc  41.00 %$ 40.995 millions
Charles River Laboratories International Inc  40.60 %$ 40.601 millions
Pacific Health Care Organization Inc  37.55 %$ 37.554 millions
West Pharmaceutical Services Inc  35.64 %$ 35.638 millions
Chemed Corp  32.08 %$ 32.085 millions
Magellan Health Inc  31.32 %$ 31.321 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BASI's Profile

Stock Price

BASI's Financials

BASI's Expectations

Business Description

Fundamentals

Charts & Quotes

BASI's News

Suppliers

BASI's Competitors

Customers & Markets

Economic Indicators

BASI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com